It has been demonstrated that defensins hBD1 and hBD2 exhibit antimicrobial activity against otitis media pathogens, and the dysfunction of these defensins in patients with psoriasis could potentially increase their susceptibility to suffering otitis media [52,53]. Here, DEFB1 is linked to psoriasis.